Close Menu

With the credit crunch and declines in the stock markets, universities are struggling with losses in their endowments -- Harvard has lost 22 percent and Yale 25 percent of their respective endowments, reports Nature. The losses, says the article, are due to schools investing in hedge funds and venture capital that generally did better than the general market but were more volatile and harder to turn into cash.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.